STAR*D and Measurement-Based Care for Depression: Don't Toss Out the Baby!

Fava M Rush AJ Trivedi MH Background and rationale for the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study. Psychiatr Clin North Am. 2003;26:457–494.

Sinyor M Schaffer A Levitt A. The Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial: A review. Can J Psychiatry. 2010;55:126–135.

Trivedi MH Rush AJ Gaynes BN Maximizing the adequacy of medication treatment in controlled trials and clinical practice: STAR*D measurement-based care. Neuropsychopharmacology. 2007;32:2479–2489.

Pigott HE . The STAR*D trial: It is time to reexamine the clinical beliefs that guide the treatment of major depression. Can J Psychiatry. 2015;60(1):9–13.

Rush AJ Trivedi MH Wisniewski SR Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. N Engl J Med. 2006;354:1231–1242.

Trivedi MH Fava M Wisniewski SR Medication augmentation after the failure of SSRIs for depression. N Engl J Med. 2006;354:1243–1252.

Thase ME Friedman ES Biggs MM Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: A STAR*D report. Am J Psychiatry. 2007;164:739–752.

Fava M Rush AJ Wisniewski SR A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: A STAR*D report. Am J Psychiatry. 2006;163:1161–1172.

Nierenberg AA Fava M Trivedi MH A comparison of lithium and T3 augmentation following two failed medication treatments for depression: A STAR*D report. Am J Psychiatry. 2006;163:1519–1530.

McGrath PJ Stewart JW Fava M Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: A STAR*D report. Am J Psychiatry. 2006;163:1531–1541.

Lam RW Kennedy SH . Evidence-based strategies for achieving and sustaining full remission in depression: Focus on metaanalyses. Can J Psychiatry. 2004;49(3 Suppl 1):17S–26S.

Paykel ES . Partial remission, residual symptoms, and relapse in depression. Dialogues Clin Neurosci. 2008;10:431–437.

Mauskopf JA Simon GE Kalsekar A Nonresponse, partial response, and failure to achieve remission: Humanistic and cost burden in major depressive disorder. Depress Anxiety. 2009;26:83–97.

Nierenberg AA Husain MM Trivedi MH Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: A STAR*D report. Psychol Med. 2010;40:41–50.

Culpepper L Trivedi MH . Using measurement-based care with patient involvement to improve outcomes in depression. Prim Care Companion CNS Disord. 2013;15(6). pii: PCC.12075co3c. doi: 10.4088/PCC.12075co3c.

Harding KJ Rush AJ Arbuckle M Measurement-based care in psychiatric practice: A policy framework for implementation. J Clin Psychiatry. 2011;72:1136–1143.

Yeung AS Jing Y Brenneman SK Clinical Outcomes in Measurement-based Treatment (Comet): A trial of depression monitoring and feedback to primary care physicians. Depress Anxiety. 2012;29:865–873.

Zimmerman M McGlinchey JB Posternak MA How should remission from depression be defined? The depressed patient's perspective. Am J Psychiatry. 2006;163:148–150.

Lam RW Filteau MJ Milev R. Clinical effectiveness: The importance of psychosocial functioning outcomes. J Affect Disord. 2011;132(Suppl 1):S9–S13.

Greer TL Kurian BT Trivedi MH . Defining and measuring functional recovery from depression. CNS Drugs. 2010;24:267–284.

Lam RW Parikh S V Michalak EE Canadian Network for Mood and Anxiety Treatments (CANMAT) consensus recommendations for functional outcomes in major depressive disorder. Ann Clin Psychiatry. Forthcoming.

Patten SB Kennedy SH Lam RW Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. I. Classification, burden and principles of management. J Affect Disord. 2009;117(Suppl 1):S5–S14.

Cohen RM Greenberg JM IsHak WW . Incorporating multidimensional patient-reported outcomes of symptom severity, functioning, and quality of life in the Individual Burden of Illness Index for Depression to measure treatment impact and recovery in MDD. JAMA Psychiatry. 2013;70:343–350.

Valenstein M Adler DA Berlant J Implementing standardized assessments in clinical care: Now's the time. Psychiatr Serv. 2009;60:1372–1375.

Zimmerman M Young D Chelminski I Overcoming the problem of diagnostic heterogeneity in applying measurement-based care in clinical practice: The concept of psychiatric vital signs. Compr Psychiatry. 2012;53:117–124.

Kennedy SH Downar J Evans KR The Canadian Biomarker Integration Network in Depression (CAN-BIND): Advances in response prediction. Curr Pharm Design. 2012;18:5976–5989.